Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Wynckel

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Kidney International|June 25, 2022
Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathySophie Chauvet, Jill J Hauer, Florent Petitprez, et al.
Blood|September 12, 2018
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Ygal Benhamou, An-Sofie Schelpe, et al.
Blood|November 5, 2020
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTPPaul Coppo, Michael Bubenheim, Elie Azoulay, et al.
American Journal of Hematology|July 15, 2025
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTPMarie Robert, Arthur Mageau, Ygal Benhamou, et al.
Clinical Kidney Journal|December 23, 2020
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohortGuillaume Lano, Antoine Braconnier, Stanislas Bataille, et al.
Kidney International|March 2, 2024
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathiesValentin Maisons, Anna Duval, Laurent Mesnard, et al.
Emerging Infectious Diseases|June 21, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017Benoît Travert, Antoine Dossier, Matthieu Jamme, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GNMarie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Plos One|September 16, 2017
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsMikael Ebbo, Aurélie Grados, Maxime Samson, et al.
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Kidney International|June 25, 2022
Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathySophie Chauvet, Jill J Hauer, Florent Petitprez, et al.
Blood|September 12, 2018
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Ygal Benhamou, An-Sofie Schelpe, et al.
Blood|November 5, 2020
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTPPaul Coppo, Michael Bubenheim, Elie Azoulay, et al.
American Journal of Hematology|July 15, 2025
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTPMarie Robert, Arthur Mageau, Ygal Benhamou, et al.
Clinical Kidney Journal|December 23, 2020
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohortGuillaume Lano, Antoine Braconnier, Stanislas Bataille, et al.
Kidney International|March 2, 2024
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathiesValentin Maisons, Anna Duval, Laurent Mesnard, et al.
Emerging Infectious Diseases|June 21, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017Benoît Travert, Antoine Dossier, Matthieu Jamme, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GNMarie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Plos One|September 16, 2017
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsMikael Ebbo, Aurélie Grados, Maxime Samson, et al.
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Pageof 6